Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

David Malcom Rodman Insider Profile

11 Followers

David Malcom Rodman, CMO at Mineralys Therapeutics, Inc., holds 51.38K shares in Mineralys Therapeutics, Inc. (Ticker: MLYS).

David Malcom Rodman's Trading History

MLYSMineralys Therapeutics, Inc.		Aug 12, 2026CMOUninformative Buy34.72K$787.72K
MLYS
Insider Shares: 51.38K (0.06%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 12, 2026Uninformative Sell$58.79K2,170$27.09―
Aug 12, 2026Uninformative Buy$34.72K2,170$16.00―
Jul 20, 2026Uninformative Sell$11.04K416$26.53―
Jul 20, 2026Uninformative Buy$6.42K416$15.44―
Jul 10, 2026Uninformative Sell$65.78K2,171$30.30―
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

David Malcom Rodman insider profile FAQ

What stocks does David Malcom Rodman hold?
David Malcom Rodman holds: MLYS stocks.
What was David Malcom Rodman’s latest transaction?
David Malcom Rodman’s latest transaction was an Uninformative Buy of $34.72K.
What is David Malcom Rodman's role in Mineralys Therapeutics, Inc.?
David Malcom Rodman's role in Mineralys Therapeutics, Inc. is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.